1. El-Hattab, Ayman W, Craigen, William J, Scaglia, Fernando. 2017. Mitochondrial DNA maintenance defects. In Biochimica et biophysica acta. Molecular basis of disease, 1863, 1539-1555. doi:10.1016/j.bbadis.2017.02.017. https://pubmed.ncbi.nlm.nih.gov/28215579/
2. Finsterer, Josef, Zarrouk-Mahjoub, Sinda. 2017. Phenotypic and Genotypic Heterogeneity of RRM2B Variants. In Neuropediatrics, 49, 231-237. doi:10.1055/s-0037-1609039. https://pubmed.ncbi.nlm.nih.gov/29241262/
3. Jørgensen, Charlotte L T, Ejlertsen, Bent, Bjerre, Karsten D, Nielsen, Dorte L, Nielsen, Kirsten V. 2013. Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine. In BMC cancer, 13, 541. doi:10.1186/1471-2407-13-541. https://pubmed.ncbi.nlm.nih.gov/24215511/
4. Cho, Er-Chieh, Kuo, Mei-Ling, Cheng, Jia-Hui, Hsieh, Rong-Hong, Yen, Yun. 2015. RRM2B-Mediated Regulation of Mitochondrial Activity and Inflammation under Oxidative Stress. In Mediators of inflammation, 2015, 287345. doi:10.1155/2015/287345. https://pubmed.ncbi.nlm.nih.gov/26089597/
5. Iwanicka-Pronicka, Katarzyna, Ciara, Elżbieta, Piekutowska-Abramczuk, Dorota, Pajdowska, Magdalena, Pronicki, Maciej. 2019. Congenital cochlear deafness in mitochondrial diseases related to RRM2B and SERAC1 gene defects. A study of the mitochondrial patients of the CMHI hospital in Warsaw, Poland. In International journal of pediatric otorhinolaryngology, 121, 143-149. doi:10.1016/j.ijporl.2019.03.015. https://pubmed.ncbi.nlm.nih.gov/30909120/